Newer Cephalosporins are Only Marginal Advancements Over Existing Compounds

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 15, 2 Issues, 2017

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Newer Cephalosporins are Only Marginal Advancements Over Existing Compounds

Anti-Infective Agents, 1(3): 281-292.

Author(s): Mario Cazzola, Francesco Blasi and Maria Gabriella Matera.

Affiliation: Via del Parco Margherita 24, 80121 Napoli, Italy


Multidrug-resistant Gram-positive bacteria have become an increasing problem for the management of serious infections. Also extended-spectrum β-lactamase producing Gram-negative bacilli is a growing concern. A number of novel parenteral or oral cephalosporins have been synthesized and evaluated in vitro in order to overcome these resistances. In particular, today research in the cephem field is more focused on narrow spectrum antibacterials. Unfortunately, many new compounds will not be studied in clinical setting because they only show a slight improvement over existing therapies that does not justify the excessive costs involved in the development of a new chemical entity. We believe that the continuous attempts to discover structural changes able to induce real improvements in the spectrum of action of cephalosporins are now unproductive, probably because there is no room for further really useful modifications.


new cephalosporin, parenteral cephalosporin.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 1
Issue Number: 3
First Page: 281
Last Page: 292
Page Count: 12
DOI: 10.2174/1568012023354893
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science